fashion -WSS

fashion

author：entertainment 2025-09-28 10:52:44 - browse：23

Sammy Kimball for STAT

What can Homer teach us about biotech? Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. We also discuss the latest news in the life sciences, including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant.

For more on what we cover, here’s the news on BridgeBio; here’s more on the Stanford president; here’s the latest on the Pfizer plant; here’s the story on Eli Lilly’s Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Peter Hotez and the public health issue of online harassment
Next article： UnitedHealth sued over use of algorithm in Medicare Advantage plans

WSS

Eli Lilly expects to double planned employment in Boston center

Ventyx halts psoriasis drug development after lackluster trial results

Type 2 diabetes prevention programs work at large scale: study

After decades in use, heart stents finally beat placebo

How climate

What is STAT's opinion section for?

explore

fashion

explore

Cancer drug shortages should be causing more outrage

Medicare reduced heart disease by changing how it pays doctors

Cancer drug shortages should be causing more outrage

A letter from the executive editor: STAT UnitedHealth investigation

Wildfire smoke exposes gaps in outdoor worker protections

Will Ozempic

United colonoscopy coverage change 'may cost lives,' doctors say

Solve the antibiotic resistance crisis with preventive drugs

DIEP, the 'gold standard' of breast reconstruction, is under threat

CVS, Rite Aid closures threaten to worsen pharmacy deserts

focus

UnitedHealth sued over use of algorithm in Medicare Advantage plans

What is STAT's opinion section for?

Ventyx halts psoriasis drug development after lackluster trial results

STAT Summit: How a Chicago ER doctor tackles gun violence

How state and local governments are sidelining science

STAT Summit: Biotech founders on deal

Wikipedia

leisure time

leisure time

hotspot